Page last updated: 2024-11-07

spironolactone and Cardiac Rupture, Traumatic

spironolactone has been researched along with Cardiac Rupture, Traumatic in 2 studies

Spironolactone: A potassium sparing diuretic that acts by antagonism of aldosterone in the distal renal tubules. It is used mainly in the treatment of refractory edema in patients with congestive heart failure, nephrotic syndrome, or hepatic cirrhosis. Its effects on the endocrine system are utilized in the treatments of hirsutism and acne but they can lead to adverse effects. (From Martindale, The Extra Pharmacopoeia, 30th ed, p827)
spironolactone : A steroid lactone that is 17alpha-pregn-4-ene-21,17-carbolactone substituted by an oxo group at position 3 and an alpha-acetylsulfanyl group at position 7.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Pojoga, LH1
Yao, TM1
Opsasnick, LA1
Siddiqui, WT1
Reslan, OM1
Adler, GK1
Williams, GH1
Khalil, RA1
McMahon, EG1

Reviews

1 review available for spironolactone and Cardiac Rupture, Traumatic

ArticleYear
Eplerenone, a new selective aldosterone blocker.
    Current pharmaceutical design, 2003, Volume: 9, Issue:13

    Topics: Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Animals; Cardiovascular System; Disease Model

2003

Other Studies

1 other study available for spironolactone and Cardiac Rupture, Traumatic

ArticleYear
Cooperative Role of Mineralocorticoid Receptor and Caveolin-1 in Regulating the Vascular Response to Low Nitric Oxide-High Angiotensin II-Induced Cardiovascular Injury.
    The Journal of pharmacology and experimental therapeutics, 2015, Volume: 355, Issue:1

    Topics: Angiotensin II; Animals; Aorta; Blood Pressure; Cardiovascular System; Caveolin 1; Cyclic GMP; Epler

2015